October 17, 2018 NIAID Funding News
Read this full issue online at http://www.niaid.nih.gov/
Feature Articles
Notes from September Advisory Council—Budgets, News, Approved Concepts
If you missed the September 17, 2018 meeting of NIAID’s Advisory Council, you can watch a videocast of remarks from NIAID Director Dr. Anthony Fauci and NIAID Division of Intramural Research Director Dr. Steven Holland, as well as open subcommittee sessions.
Opportunities and Resources
Up for a “Grand Challenge”? The Gates Foundation Has a Few for You
We highlight three grant opportunities from the Bill and Melinda Gates Foundation that focus on health science topics also of interest to NIAID.
NIAID seeks innovative research on innate and adaptive immune responses induced by mycobacterial infection, Bacillus Calmette-Guérin vaccine, or other Mycobacterium tuberculosisvaccinations.
NIAID invites principal investigators to request additional funds to hire a mid-to-senior level technician at a full-time or part-time level of effort to help maintain an eligible postdoctoral scientist’s projects when he or she is required to be away from the lab to fulfill caregiver obligations.
In The News
We Have Interim R01 Paylines and an Appropriation
For the first time in 22 years, Congress passed the HHS budget appropriation before the start of the fiscal year!
NIH issued a competitive revisions (Type 3) funding opportunity announcement to accept urgent award applications whenever an NIH institute or center publishes an Urgent Award Notice to define an urgent need in response to a public health crisis.
All NIH new (including renewals) and continuation awards beginning on or after October 1, 2018, are subject to the new final regulations of the Bayh-Dole Act of 1980.
For those who couldn’t make it in person—and those who did but want a refresher—NIH has posted various resources on the Workshop webpage, including the webcast in its entirety.
Advice Corner
Two New Sample Applications Demonstrate Rigor and Reproducibility
We recently added two new R01 applications and summary statements. Since these sample applications were submitted using FORMS-D, they fulfill the rigor and reproducibility requirements NIH introduced in 2016.
Reader Questions
- “For a resubmission, can I reuse letters of support from the initial application or am I required to obtain updated letters of support?”
- “What dictates whether AIDS dates apply to an application? For example, would a fellowship application with an AIDS-related project qualify?”
New Funding Opportunities
- RFP-NIAID-DMID-NIHAI201800005, Bioinformatics Resource Centers for Infectious Diseases
- RFA-AI-18-045, Radiation Biodosimetry Assays and Devices (U01 Clinical Trial Not Allowed)
- RFA-AI-18-042, Fc-Dependent Mechanisms of Antibody-Mediated Killing (U01 Clinical Trial Not Allowed)
- PA-19-020, Fc-Dependent Mechanisms of Antibody-Mediated Killing (R21 Clinical Trial Not Allowed)
- PA-18-935, Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)
See other announcements at Opportunities & Announcements.
Send suggestions or comments to deaweb@niaid.nih.gov.
.png)
No hay comentarios:
Publicar un comentario